Fremont Rachel, Tewari Ambika, Angueyra Chantal, Khodakhah Kamran
Dominick P. Purpura Department of Neuroscience, Albert Einstein College of Medicine, New York, United States.
Elife. 2017 Feb 15;6:e22775. doi: 10.7554/eLife.22775.
DYT1 is a debilitating movement disorder caused by loss-of-function mutations in torsinA. How these mutations cause dystonia remains unknown. Mouse models which have embryonically targeted torsinA have failed to recapitulate the dystonia seen in patients, possibly due to differential developmental compensation between rodents and humans. To address this issue, torsinA was acutely knocked down in select brain regions of adult mice using shRNAs. TorsinA knockdown in the cerebellum, but not in the basal ganglia, was sufficient to induce dystonia. In agreement with a potential developmental compensation for loss of torsinA in rodents, torsinA knockdown in the immature cerebellum failed to produce dystonia. Abnormal motor symptoms in knockdown animals were associated with irregular cerebellar output caused by changes in the intrinsic activity of both Purkinje cells and neurons of the deep cerebellar nuclei. These data identify the cerebellum as the main site of dysfunction in DYT1, and offer new therapeutic targets.
DYT1是一种由torsinA功能丧失突变引起的使人衰弱的运动障碍。这些突变如何导致肌张力障碍仍然未知。胚胎期靶向torsinA的小鼠模型未能重现患者中出现的肌张力障碍,这可能是由于啮齿动物和人类之间不同的发育补偿所致。为了解决这个问题,使用短发夹RNA(shRNAs)在成年小鼠的特定脑区急性敲低torsinA。在小脑中敲低torsinA,但不在基底神经节中敲低,足以诱发肌张力障碍。与啮齿动物中torsinA缺失的潜在发育补偿一致,在未成熟小脑中敲低torsinA未能产生肌张力障碍。敲低动物中的异常运动症状与浦肯野细胞和小脑深部核团神经元的内在活动变化引起的不规则小脑输出有关。这些数据确定小脑是DYT1功能障碍的主要部位,并提供了新的治疗靶点。